MX9504215A - Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica. - Google Patents

Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica.

Info

Publication number
MX9504215A
MX9504215A MX9504215A MX9504215A MX9504215A MX 9504215 A MX9504215 A MX 9504215A MX 9504215 A MX9504215 A MX 9504215A MX 9504215 A MX9504215 A MX 9504215A MX 9504215 A MX9504215 A MX 9504215A
Authority
MX
Mexico
Prior art keywords
oligopeptides
daltons
improved process
purify
molecular weights
Prior art date
Application number
MX9504215A
Other languages
English (en)
Inventor
Sergio Antonio Estrada Parra
Carlos Adolfo Perez De La Mora
Original Assignee
Inst Politecnico Nacional
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Politecnico Nacional filed Critical Inst Politecnico Nacional
Priority to MX9504215A priority Critical patent/MX9504215A/es
Priority to AU70985/96A priority patent/AU7098596A/en
Priority to PCT/MX1996/000018 priority patent/WO1997012915A1/es
Publication of MX9504215A publication Critical patent/MX9504215A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion se refiere a un procedimiento mejorado para el fraccionamiento con alto rendimiento, de un conjunto de oligopéptidos (de 1000 a 10000 daltones), recuperados a partir del rompimiento de leucocitos y que poseen actividad biologica para la regulacion de la respuesta inmune que comprende los siguientes pasos: a partir de paquetes leucocitarios de donadores sanos, TODO BAJO CONDICIONES ASEPTICAS, se rompen las células, se hacen suspensiones ajustando volumenes, y mediante ultracentrifugacion, se clarifica la suspension de los restos celulares (detritus celulares), se recuperan los oligopéptidos por medio de diafiltracion y se concentran por ultrafiltracion tangencial. Se formula el producto con base en su formula de producto terminado en presentacion farmacéutica.
MX9504215A 1995-10-05 1995-10-05 Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica. MX9504215A (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX9504215A MX9504215A (es) 1995-10-05 1995-10-05 Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica.
AU70985/96A AU7098596A (en) 1995-10-05 1996-10-02 Process for purifying the transfer factor from leucocytes
PCT/MX1996/000018 WO1997012915A1 (es) 1995-10-05 1996-10-02 Procedimiento de purificacion del factor de transferencia a partir de leucocitos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9504215A MX9504215A (es) 1995-10-05 1995-10-05 Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica.

Publications (1)

Publication Number Publication Date
MX9504215A true MX9504215A (es) 1997-04-30

Family

ID=19744888

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9504215A MX9504215A (es) 1995-10-05 1995-10-05 Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica.

Country Status (3)

Country Link
AU (1) AU7098596A (es)
MX (1) MX9504215A (es)
WO (1) WO1997012915A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358703B1 (en) 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
EP1596667B1 (en) * 2002-11-01 2009-01-21 Bayer HealthCare LLC Process for the concentration of proteins
MX338863B (es) * 2011-12-16 2016-05-01 Inst Politecnico Nacional Metodo de obtencion de extracto dializable de leucocitos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000790A1 (en) * 1978-10-25 1980-05-01 Benzon As Alfred Transfer factor and method for producing same
CH656068A5 (en) * 1983-01-06 1986-06-13 Bezirksblutspendezentrale Plau Process for the preparation of human transfer factor products
WO1992000087A1 (en) * 1990-07-02 1992-01-09 National Jewish Center For Immunology And Respiratory Medicine Process for obtaining pure peptide transfer factor, transfer factor thus obtained and uses thereof
DD301781A7 (de) * 1990-09-12 1994-09-15 Cyto Chemia Biolog Pharmazeuti Virussichere humane Transfer-Faktor-Praeparate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
AU7098596A (en) 1997-04-28
WO1997012915A1 (es) 1997-04-10

Similar Documents

Publication Publication Date Title
Pytela et al. [27] Arginine-glycine-aspartic acid adhesion receptors
NZ302984A (en) Multifunctional enzyme having N-terminal sequence IVGGXEVTPHAYPWQVGLFIDDMYF, where X is any amino acid
NZ320802A (en) Purified mannanase from Bacillus amyloliquefaciens
EP0035202A2 (en) Method of blood plasma fractionation
IT1256692B (it) Procedimento di preparazione su scala industriale di un concentrato standardizzato di fattore von willebrand umano di altissima purezza ed adatto ad uso terapeutico.
Sidman et al. B cell maturation factor (BMF): a lymphokine or family of lymphokines promoting the maturation of B lymphocytes.
CA2481936A1 (en) Canola protein isolate compositions
AU7208296A (en) Transferrin receptor protein of moraxella
KR880012765A (ko) 신규의 글리코프로테인, 이의 생산방법 및 유효성분으로서 이를 함유하는 면역억제제
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
IL106975A0 (en) Nutrition for persons infected with human immunodeficiency virus
EP1308553A3 (en) Functional fiber products and process for producing same
Temesvari et al. Characterization of lysosomal membrane proteins of Dictyostelium discoideum. A complex population of acidic integral membrane glycoproteins, Rab GTP-binding proteins and vacuolar ATPase subunits.
Daha et al. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro
Zwerner et al. Isolation and characterization of murine cell surface components. I. Purification of milligram quantities of Thy-1.1
ATE97448T1 (de) Verfahren zur isolierung von ca 125-antigen.
GB9011777D0 (en) Hv/hb copolymer production
TW273521B (es)
MX9504215A (es) Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica.
Bakacs et al. EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients
PL316935A1 (en) Heparin bonding protein for treating septicaemia and method of obtaining such protein
EP0465495A1 (en) Ribozome inactivating proteins and derivatives thereof
EP0462792B1 (en) Process for obtaining cellular protein having anti-HIV activity
DE69623272D1 (de) Isolierte proteine mit 55-75 kda, die an das prion-protein anbinden
Räsänen et al. Elaboration of leukocyte migration inhibitory factor by human lymphocyte subpopulations stimulated with mitogens